Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 10M | 8M |
| Research and development | 86M | 66M |
| Selling, general and administrative | 34M | 29M |
| Operating expenses | 120M | 100M |
| Operating income | −110M | −91M |
| Net income | −109M | −89M |
| Earnings per share | −0.34 | −0.36 |
| Earnings per share, diluted | −0.34 | −0.36 |
| Weighted average shares | 320M | 250M |
| Weighted average shares, diluted | 320M | 250M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 277M | 320M | 297M | 313M | 117M | 139M | 158M | 173M |
| Current assets | 282M | 325M | 300M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −93M | −81M |
| Depreciation and amortisation | 1M | 1M |
| Share-based compensation | 13M | 13M |
| Capital expenditure | 738,000 | 374,000 |
| Investing cash flow | −604,000 | −363,000 |
| Financing cash flow | 275M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 316M |
| 121M |
| 142M |
| 162M |
| 178M |
| Property, plant and equipment | 6M | 7M | 7M | 7M | 7M | 7M | 8M | 11M |
| Total assets | 300M | 343M | 317M | 333M | 138M | 160M | 180M | 200M |
| Current liabilities | 20M | 27M | 29M | 25M | 23M | 26M | 29M | 34M |
| Long-term debt | 49M | 50M | 51M | 41M | 42M | 44M | 43M | 38M |
| Total liabilities | 88M | 96M | 98M | 85M | 83M | 89M | 91M | 92M |
| Equity | 212M | 247M | 219M | 249M | 55M | 72M | 89M | 109M |
| Shares outstanding | 287M | 285M | 274M | 273M | 205M | 205M | 205M | 201M |
| Shares issued | 287M | 285M | 274M | 273M | 205M | 205M | 205M | 201M |
| 77M |